Community Acquired Pneumonia (CAP) Market by IndustryARC

Community Acquired Pneumonia Market By Materials, By Product, By Preparation Method, By Application and By Geography Analysis - Forecast 2019 - 2024 www.industryarc.com

sales@industryarc.com

Community Acquired Pneumonia Market 2019-2024

Industry Market Research for Business Leaders, Strategists, Decision Makers

Press Release According to report released by WHO, the cost of antibiotic treatment for maternal, newborn, and child survival is around US$ 109 million per year. According to recent intelligent report by IndustryARC, region with high rate of rural areas globally are prone to pneumonia with higher rate of mortality due to inaccessibility of proper medication, hygiene and food facility. However, government and health organization’s initiatives to increment awareness regarding keeping community clean as well as provide rapid support is stroking demand in the CAP market. The report is titled “Community Acquired Pneumonia (CAP) Market: By Testing & Diagnosis (Chest X-ray/radiography, Sputum Gram stain and/or culture, Blood Cultures), By Therapies & Drugs, By Patient Age group & By Geography – Forecast (2018 - 2023).” Global Community Acquired Pneumonia Market: Demand Galore Community acquired pneumonia (CAP) is an infectious disease that affects lungs due to bacterial or virus attack. Symptoms of CAP generally include fever, cough, chills, dyspnea, fatigue, rigors, and pleuritic chest pain. Patient age is the main differentiation between typical pneumonia caused by bacteria in young adults whereas atypical pneumonia caused by influenza virus, mycoplasma, chlamydia, legionella and other unidentified microorganism in very young and older person. About 20% of the patients affected by CAP are forced to resort to hospitalization, and among them, 16% CAP causes death. CAP is the major causes of high mortality. Identification of CAP at an early stage and its quick and appropriate treatment can cure fatality. CAP treatment requires hospitalization for a period, wherein the patient is administered with cough medicine, antipyretics that is nonsteroidal anti-inflammatory drug and antibiotics. According to the recent report from NCBI, 2.4% of patients admitted to the hospital with community-acquired pneumonia die within 72 hours of admission. Physician advice patients of CAP to avoid consumption of alcohol and tobacco as these can be toxic for their body. Taking proper vaccination, regular checkups can cure the disease. Browse 60 Market Tables, 177 Figures spread through 163 slides and an in-depth TOC on “ Community Acquired Pneumonia (CAP) Market (2018 - 2023)” Community Acquired Pneumonia Market: Disruptive Trend More research needs to be done on the different pathogens causing pneumonia and the ways they are transmitted, as this is of critical importance for treatment and prevention. The WHO and UNICEF integrated a plan aim to protect, prevent, and treat pneumonia in children. Some actions taken by them are reducing household pollution, HIV prevention, proper vaccination, and adequate supply of antibiotics and oxygen along with healthy feeding. Countries including Bangladesh, India, Kenya, Uganda and Zambia have developed district, state and national plans to intensify actions for the control of pneumonia and diarrhoea. Many more have integrated diarrhoea and pneumonia-specific action into their national child health and child survival strategies. All these initiatives are translating into influx of investment from private and public sectors and driving the demand in the global community acquired pneumonia market. Community acquired pneumonia is a global infectious diseases that effects lungs due to bacterial or virus attack. CAP is the major causes of high mortality. Identification of CAP at early stage and its quick and appropriate treatment can cure fatality. Government initiatives and prosperity of some of the emerging economies are generating substantial demand in the community acquired pneumonia market. Talk to one of our sales representative about the full report by providing your details in the link below: https://industryarc.com/support.php?id=15560

Community Acquired Pneumonia Market

Related Reports: Infection prevention & Control Market: By Infections (Microbial & Others); By Antimicrobial Drugs (Antibacterial & Others); By Accessories & Equipment (Disinfectants & Others); By End User (Equipment & Drug Usage) & By Geography - Forecast (2018-2023) https://industryarc.com/Report/1309/Infection-Prevention-and-Control-Market-analysis-report.html Oxygen Therapy Devices Market: By Product Type (O2 Source Equipment & O2 Delivery Devices), By Applications (Chronic Obstructive Pulmonary Disease, Asthma and Others) & By Geography Forecast(2018 - 2023) https://industryarc.com/Report/16190/oxygen-therapy-devices-market.html/summary About IndustryARC: IndustryARC is a research and consulting firm that publishes more than 500 reports annually in various industries, such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences & Healthcare. IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications of the Market. Our Custom Research Services are designed to provide insights into the constant flux in the global demand-supply gap of markets. Our strong analyst team enables us to meet the client research needs at a very quick speed with a variety of options for your business. We look forward to supporting the client to be able to better address customer needs; stay ahead in the market; become the top competitor and get real-time recommendations on business strategies and deals. Contact us to find out how we can help you today. Contact Us: Mr. Venkateshwar Reddy Business Development Manager Email: sales@industryarc.com Contact Sales: 1-614-588-8538 (Ext-101) Connect with us on LinkedIn - https://www.linkedin.com/company/industryarc

Community Acquired Pneumonia Market

Industry Market Research for Business Leaders, Strategists, Decision Makers

Table of Contents 1. Community Acquired Pneumonia (CAP) Market - Overview 1.1. Definitions and Scope 2. Community Acquired Pneumonia (CAP) Market - Executive summary 2.1. Market Revenue, Market Size and Key Trends by Company 2.2. Key Trends by type of Application 2.3. Key Trends segmented by Geography 3. Community Acquired Pneumonia (CAP) Market 3.1. Comparative analysis 3.1.1. Product Benchmarking - Top 10 companies 3.1.2. Top 5 Financials Analysis 3.1.3. Market Value split by Top 10 companies 3.1.4. Patent Analysis - Top 10 companies 3.1.5. Pricing Analysis 4. Community Acquired Pneumonia (CAP) Market – Startup companies Scenario 4.1. Top 10 startup company Analysis by 4.1.1. Investment 4.1.2. Revenue 4.1.3. Market Shares 4.1.4. Market Size and Application Analysis 4.1.5. Venture Capital and Funding Scenario 5. Community Acquired Pneumonia (CAP) Market – Industry Market Entry Scenario 5.1. Regulatory Framework Overview 5.2. New Business and Ease of Doing business index 5.3. Case studies of successful ventures 5.4. Customer Analysis – Top 10 companies 6. Community Acquired Pneumonia (CAP) Market Forces 6.1. Drivers 6.2. Constraints 6.3. Challenges 6.4. Porters five force model 6.4.1. Bargaining power of suppliers 6.4.2. Bargaining powers of customers 6.4.3. Threat of new entrants 6.4.4. Rivalry among existing players 6.4.5. Threat of substitutes 7. Community Acquired Pneumonia (CAP) Market - Strategic analysis 7.1. Value chain analysis 7.2. Opportunities analysis 7.3. Product life cycle 7.4. Suppliers and distributors Market Share 8. Community Acquired Pneumonia (CAP) Market – By Testing & Diagnosis (Market Size -$Million / $Billion) 8.1. Market Size and Market Share Analysis 8.2. Application Revenue and Trend Research 8.3. Product Segment Analysis 8.3.1. Chest X-ray/radiography 8.3.2. Sputum Gram stain and/or culture 8.3.3. Blood Cultures 8.3.4. Others

Community Acquired Pneumonia Market

8.3.4.1. COMPLETE BLOOD CELL (CBC) COUNT 8.3.4.2. SERUM SODIUM LEVEL 8.3.4.3. SERUM BLOOD UREA NITROGEN (BUN) AND CREATININE LEVELS 8.3.4.4. SERUM TRANSAMINASE LEVELS 8.3.4.5. SERUM PHOSPHORUS LEVEL 8.3.4.6. LACTIC ACID LEVEL 8.3.4.7. CREATINE PHOSPHOKINASE (CPK) 8.3.4.8. C-REACTIVE PROTEIN (CRP) 8.3.4.9. LACTATE DEHYDROGENASE (LDH) 8.3.4.10. PROCALCITONIN 8.3.4.11. COLD AGGLUTININ TITERS 8.3.4.12. URINARY ANTIGEN TESTING 8.3.4.13. SEROLOGIC STUDIES FOR M PNEUMONIAE 8.3.4.14. POLYMERASE CHAIN REACTION (PCR) TESTING 9. Community Acquired Pneumonia (CAP) Market – By Therapies & Drugs (Market Size -$Million / $Billion) 9.1. Antiviral Threapy 9.1.1. RIBAVIRIN 9.1.2. OSELTAMIVIR 9.1.3. ZANAMIVIR 9.1.4. ACYCLOVIR 9.2. Antibiotic Threapy 9.2.1. AMOXICILLIN 9.2.2. AZITHROMYCIN OR CLARITHROMYCIN 9.2.3. AMPICILLIN 9.2.4. VANCOMYCIN OR CLINDAMYCIN 9.2.5. CEFTRIAXONE OR CEFOTAXIME 9.2.6. GENTAMICIN 10. Community Acquired Pneumonia (CAP) Market – By Drugs provided to different age groups (Market Size -$Million / $Billion) 10.1. Newborns 10.1.1. AMPICILLIN 10.1.2. GENTAMICIN 10.2. Children 10.2.1. AMOXICILLIN 10.2.2. CEFPODOXIME 10.2.3. AMPICILLIN 10.2.4. CEFTRIAXONE OR CEFOTAXIME 10.3. Adults 10.3.1. AZITHROMYCIN OR CLARITHROMYCIN 10.3.2. CEFPODOXIME 10.3.3. AMOXICILLIN 10.3.4. CEFTRIAXONE OR CEFOTAXIME 11. Community Acquired Pneumonia (CAP) - By Geography (Market Size -$Million / $Billion) 11.1. Community Acquired Pneumonia (CAP) Market - North America Segment Research 11.2. North America Market Research (Million / $Billion) 11.2.1. Segment type Size and Market Size Analysis 11.2.2. Revenue and Trends 11.2.3. Application Revenue and Trends by type of Application 11.2.4. Company Revenue and Product Analysis 11.2.5. North America Product type and Application Market Size 11.2.5.1. U.S. 11.2.5.2. Canada 11.2.5.3. Mexico 11.2.5.4. Rest of North America 11.3. Community Acquired Pneumonia (CAP) - South America Segment Research 11.4. South America Market Research (Market Size -$Million / $Billion) 11.4.1. Segment type Size and Market Size Analysis

Community Acquired Pneumonia Market

11.4.2. Revenue and Trends 11.4.3. Application Revenue and Trends by type of Application 11.4.4. Company Revenue and Product Analysis 11.4.5. South America Product type and Application Market Size 11.4.5.1. Brazil 11.4.5.2. Venezuela 11.4.5.3. Argentina 11.4.5.4. Ecuador 11.4.5.5. Peru 11.4.5.6. Colombia 11.4.5.7. Costa Rica 11.4.5.8. Rest of South America 11.5. Community Acquired Pneumonia (CAP) - Europe Segment Research 11.6. Europe Market Research (Market Size -$Million / $Billion) 11.6.1. Segment type Size and Market Size Analysis 11.6.2. Revenue and Trends 11.6.3. Application Revenue and Trends by type of Application 11.6.4. Company Revenue and Product Analysis 11.6.5. Europe Segment Product type and Application Market Size 11.6.5.1. U.K 11.6.5.2. Germany 11.6.5.3. Italy 11.6.5.4. France 11.6.5.5. Netherlands 11.6.5.6. Belgium 11.6.5.7. Spain 11.6.5.8. Denmark 11.6.5.9. Rest of Europe 11.7. Community Acquired Pneumonia (CAP) – APAC Segment Research 11.8. APAC Market Research (Market Size -$Million / $Billion) 11.8.1. Segment type Size and Market Size Analysis 11.8.2. Revenue and Trends 11.8.3. Application Revenue and Trends by type of Application 11.8.4. Company Revenue and Product Analysis 11.8.5. APAC Segment – Product type and Application Market Size 11.8.5.1. China 11.8.5.2. Australia 11.8.5.3. Japan 11.8.5.4. South Korea 11.8.5.5. India 11.8.5.6. Taiwan 11.8.5.7. Malaysia 12. Community Acquired Pneumonia (CAP) Market - Entropy 12.1. New product launches 12.2. M&A's, collaborations, JVs and partnerships 13. Community Acquired Pneumonia (CAP) Market – Industry / Segment Competition landscape 13.1. Market Share Analysis 13.1.1. Market Share by Country- Top companies 13.1.2. Market Share by Region- Top 10 companies 13.1.3. Market Share by type of Application – Top 10 companies 13.1.4. Market Share by type of Product / Product category- Top 10 companies 13.1.5. Market Share at global level- Top 10 companies 13.1.6. Best Practises for companies 14. Community Acquired Pneumonia (CAP) Market – Key Company List by Country 15. Community Acquired Pneumonia (CAP) Market Company Analysis 15.1. Market Share, Company Revenue, Products, M&A, Developments 15.2. Pfizer 15.3. Astrazeneca Plc.

Community Acquired Pneumonia Market

15.4. Bioaegis Therapeutics, Inc 15.5. Biotest AG 15.6. C10 Pharma AS 15.7. Kyorin Pharmaceutical Co., Ltd 15.8. Melinta Therapeutics, Inc 15.9. Merck & Co., Inc. 15.10. NABRIVA THERAPEUTICS AG 15.11. Paratek Pharmaceuticals, Inc 15.12. Company 11 15.13. Company 12 15.14. Company 13 and more "*Financials would be provided on a best efforts basis for private companies" 16. Community Acquired Pneumonia (CAP) Market - Appendix 16.1. Abbreviations 16.2. Sources 17. Community Acquired Pneumonia (CAP) Market - Methodology 17.1. Research Methodology 17.1.1. Company Expert Interviews 17.1.2. Industry Databases 17.1.3. Associations 17.1.4. Company News 17.1.5. Company Annual Reports 17.1.6. Application Trends 17.1.7. New Products and Product database 17.1.8. Company Transcripts 17.1.9. R&D Trends 17.1.10. Key Opinion Leaders Interviews 17.1.11. Supply and Demand Trends

Community Acquired Pneumonia Market

Industry Market Research for Business Leaders, Strategists, Decision Makers

IndustryARC Solutions We cater to the pain points of our clients by providing the following solutions, which are targeted and address key issues specifically. Each of the business verticals is helpful to a client at various stages of their operational, managerial and strategic level plans. Syndicate Reports and Consulting (SRC) 1. Provide high quality analytical syndicated reports with key market insights, strategies and market forecasts for a specific industry or vertical of the clients. Constant tracking of industries and relations with experts helps us to predict and publish reports before our competitors as well as meet client needs proactively. Market Research and Data Analytics (MRDA) 2. Provide pure play data analytics services for ad-hoc and long-term engagement projects of clients with market research layered into the analysis. We are the only global company to offer this combination one-stop service to clients. Redundancies generally seen by procuring data, analytics services from multiple vendors is overcome by our solution. Competitive Landscape Analysis (CLA) 3. Provide company financial analysis, market share analysis, competitive landscape insights and market movements to clients. This is one of the most important pain point and key request from majority of our clients, for which we use our proprietary methodologies to provide accurate CLA data. Accelerated Business Development (ABD) 4. Connect clients with their customers on a global scale by acting as an outsourced sales team on behalf of the client. This is a unique tri-party engagement model to benefit the client and their customer, and acts as a business development scale up at an international level. Market Intel Reports (MIR) 5. Provide one-stop venue with a searchable syndicate reports database from global companies available to clients. This augments our offerings exponentially and also assists in studying global client needs at an in-depth level.

Community Acquired Pneumonia Market

Industry Market Research for Business Leaders, Strategists, Decision Makers

About IndustryARC IndustryARC strategy studies primarily focuses on Cutting Edge Technologies and Newer Applications of the Market. Our Custom Research Services are designed to provide insights on the constant flux in the global demand-supply gap of markets. Our strong analyst team enables us to meet the client research needs at a very quick speed with a variety of options for your business. We look forward to support the client to be able to better address customer needs; stay ahead in the market; become the top competitor and get real-time recommendations on business strategies and deals.

We Work for You For IndustryARC, we value every customer equally. We only stay ready to help each client in the best way possible with a unique 24x365 support plan. We suggest looking at the following benefits of relying on Professional Business Consulting and Custom Market Research Services to realize the unique strategic gains on offer: 1. 2. 3. 4. 5. 6. 7.

Strengthen and improve organizational performance Strategic planning and analysing Adoption of newer and cost-effective technologies Become environmentally sustainable and profitable Improve their training and certification procedures. Planning for business automation. Project facilitation and management.

Community Acquired Pneumonia Market

010